S. aureus grown in milk shows 10-fold higher resistance to reactive oxygen species and increased antimicrobial tolerance compared to serum-grown bacteria.
- Open access
Moving in bioRxiv, Applied and environmental microbiology, Journal of bacteriology, Biotechnology advances, Communications Biology, FEMS microbiology reviews, mSystems, Nature.
Rebuilt
Nothing in this area has moved yet this week.
Newest first · last 60 days
S. aureus grown in milk shows 10-fold higher resistance to reactive oxygen species and increased antimicrobial tolerance compared to serum-grown bacteria.
Lacticaseibacillus rhamnosus GG boosts gefitinib efficacy by 40% and reduces gastrointestinal and hepatic toxicity in non-small cell lung cancer models.
Consuming sugar-rich foods during antibiotic treatment worsens gut microbiome disruption, increasing Enterococcus expansion and reducing microbial diversity.
ArmA, a glycosyl hydrolase from Methanobrevibacter smithii, uncovers a novel archaeal peptidoglycan structure, challenging 50 years of assumptions about archaeal cell walls.
A microbial module called the FERM guild influences hypertension through metabolic flux disruptions, involving 17 key metabolites linked to blood pressure regulation.
Clostridioides difficile produces over 28 unique N-acyl amino acids, including high levels of phenylacetic acid, distinguishing it from other gut bacteria.
Engineered native Escherichia coli strain MEc30 achieves lifelong gut colonization and sustained therapeutic delivery without disrupting host health or microbiota.
F. sanfranciscensis impairs the growth of M. humilis in sourdough, with bacteria dominating and consuming less maltose than when grown alone.
LtgB controls the timing of peptidoglycan degradation during Myxococcus xanthus sporulation, preventing premature pseudospore formation by regulating LtgA activity.
Diverse bacterial glycoside transporters exhibit significant structural, functional, and taxonomic variation, with over 100 validated examples across multiple transporter families.
Artificial probiotics engineered through advanced biotechnologies outperform natural strains in functionality, with the potential to revolutionize gut health and disease treatment.
Gut microbiota influences EHEC infection severity, with beneficial microbes providing resistance and certain species promoting virulence, impacting disease outcomes.
Journals this month
Moving areas, week to 3 Oct 2026